For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Ascensia Diabetes Care Holdings Ag

USPTO Granted Patents = 228

CIPO Patents = 33

EPO Patents = 119

Trademarks = 18

Forward Citations = 281

Loading Chart...

Loading Chart...

134 inventors (with patents filed for the assignee):

Huan-Ping Wu (56 out of 105 patents)

Igor Y Gofman (36 out of 59 patents)

Eugene Randal Prais (27 out of 43 patents)

4. Steven C Charlton (21 out of 95 patents)

5. Paul M Ripley (19 out of 30 patents)

6. Mu Wu (19 out of 34 patents)

7. Jun Chen (19 out of 29 patents)

8. Jeffery S Reynolds (17 out of 32 patents)

9. Hoi-Cheong Steve Sun (16 out of 34 patents)

10. Boru Zhu (13 out of 17 patents)

11. Simin Yao (12 out of 19 patents)

12. Harris Lieber (10 out of 19 patents)

13. Jiangfeng Fei (10 out of 19 patents)

14. Narasinha C Parasnis (10 out of 20 patents)

15. Cameron M Young (9 out of 9 patents)

Core Competencies:

Continuous Glucose Monitoring

Analyte Concentration Determination

Wearable Devices

Biosensor Inserters

Signal Filtering

NFC-Enabled Sensors

Error Detection

Medical Device Calibration

Flexible Circuit Boards

Automatic Device Activation

Sensor Assembly

Intermittent Analyte Measurement

228 patents: Sort by Forward Citations

1. 12520114 - Test sensor systems and methods using the same (2026-01-06),

2. 12514470 - Biosensor with membrane structure for steady-state and non-steady-state conditions for determining analyte concentrations (2026-01-06),

3. 12465244 - Extracting parameters for analyte concentration determination (2025-11-11),

4. 12431727 - Automatic activation of continuous glucose monitoring (CGM) transmitter (2025-09-30),

5. 12426813 - Methods and apparatus enabling coupling of an electronics unit to a base unit of a continuous analyte monitoring device (2025-09-30),

6. 12390133 - Sensor assembly apparatus and methods for continuous glucose monitors (2025-08-19),

7. 12303261 - Devices, systems, and methods for measuring analytes in interstitial fluid (2025-05-20),

8. 12295745 - Sterilized reusable wearable devices and wearable device forming methods in continuous analyte monitoring (2025-05-13),

9. 12290334 - Continuous analyte monitoring devices and systems having a long-life reusable wireless transmitter unit and application methods therefor (2025-05-06),

10. 12257045 - Tracking insertion and removal times of a continuous glucose monitoring sensor (2025-03-25),

11. 12251218 - Base units, transmitter units, wearable devices, and methods of continuous analyte monitoring (2025-03-18),

12. 12193707 - Continuous analyte monitor inserter apparatus and methods (2025-01-14),

13. 12178615 - Methods and apparatus for adaptive filtering of signals of continuous analyte monitoring systems (2024-12-31),

14. 12117414 - NFC-enabled test sensors, systems and methods using the same (2024-10-15),

15. 12097046 - Wearable continuous analyte measurement devices, biosensor inserters, and methods of use (2024-09-24),

Ascensia Diabetes Care is a global leader in the development and commercialization of innovative solutions for diabetes management. Their mission is to empower people with diabetes to live healthy and fulfilling lives. They offer a comprehensive portfolio of glucose monitoring systems, insulin delivery systems, and digital solutions that help individuals effectively manage their diabetes. With a strong focus on research and development, Ascensia Diabetes Care is dedicated to advancing diabetes care and improving the quality of life for people with diabetes worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

228 Patents

#4 in Basel

#70 in Switzerland

#3,647 in the World

Basel, Switzerland

Ascensia Diabetes Care Holdings Ag

Forward Citations = 281

134 inventors:

Huan-Ping Wu (56 out of 105 patents)

Igor Y Gofman (36 out of 59 patents)

Eugene Randal Prais (27 out of 43 patents)

4. Steven C Charlton (21 out of 95 patents)

5. Paul M Ripley (19 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…